Testing effectiveness (Phase 2)Ended earlyNCT03456817
What this trial is testing
HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis
Who this might be right for
Graft-versus-host-diseaseRelapse
AHS Cancer Control Alberta 68